{"id":640,"date":"2024-06-28T13:24:37","date_gmt":"2024-06-28T13:24:37","guid":{"rendered":"https:\/\/terviseleht.eu\/?p=640"},"modified":"2024-07-27T15:43:51","modified_gmt":"2024-07-27T15:43:51","slug":"antikeha-ravim-on-vaga-tohus-i-staadiumis-her2-vahi-vastu","status":"publish","type":"post","link":"https:\/\/terviseleht.eu\/?p=640","title":{"rendered":"Antikeha + ravim on v\u00e4ga t\u00f5hus I staadiumis HER2+ v\u00e4hi vastu"},"content":{"rendered":"\n<h3 class=\"wp-block-heading\">Dana-Farberi v\u00e4hiinstituudi teadlaste juhitud meeskond leidis, et aasta kestnud ravi antikehast ja keemiaravist valmistatud ravimiga on osutunud v\u00e4ga t\u00f5husaks 1. staadiumi HER2-positiivse rinnav\u00e4hi kordumise \u00e4rahoidmisel.<\/h3>\n\n\n\n<p>Kliinilises uuringus osales 512 varases staadiumis rinnav\u00e4higa patsienti. P\u00e4rast operatsiooni trastuzumabemtansiiniga (T-DM1) ravitud patsientidest oli 5 aasta p\u00e4rast elus 97% ja v\u00e4hist vabad. Ajakirjas <a href=\"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.23.02170\" title=\"\">Journal of Clinical Oncology<\/a> avaldatud tulemused n\u00e4itavad, et T-DM1 on selliste patsientide jaoks m\u00f5istlik ravimeetod.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>HER2+&nbsp;rinnav\u00e4hi puhul on v\u00e4hirakkudes \u00fche raku kohta ebanormaalselt suur arv HER2-geene. Normaalsetes rakkudes aitavad HER2-valgud raku sisse saata rakuv\u00e4liseid kasvusignaale, v\u00e4hirakkudes toetavad aga v\u00e4hirakkude kiiret paljunemist ja agressiivset levikut.<\/p>\n<\/blockquote>\n\n\n\n<h3 class=\"wp-block-heading\">See ravi v\u00e4hendab v\u00e4hi taastulemise ohtu oluliselt<\/h3>\n\n\n\n<p>&#8220;1. staadiumi HER2-positiivse rinnav\u00e4higa patsientidel on retsidiivide esinemissagedus 5\u201330%. Kirurgiline ravi keemiaravi ja HER2-ga seonduva antikehaga trastuzumab v\u00f5ib neil patsientidel v\u00e4hi kordumise riski oluliselt v\u00e4hendada. Kuid k\u00f5rvaltoimed v\u00f5ivad avaldada kahjulikku m\u00f5ju patsientide elukvaliteedile,&#8221; \u00fctleb uuringu juhtiv autor Paolo Tarantino.&nbsp;<\/p>\n\n\n\n<p>T-DM1, tuntud kui antikeha-ravimi konjugaat, on praegu heaks kiidetud operatsioonij\u00e4rgseks v\u00f5i adjuvantseks raviks patsientidel, kellel on HER2-positiivne rinnav\u00e4hk, mis j\u00e4\u00e4b p\u00e4rast operatsioonieelset ravi alles, ning ka metastaatilise HER2-ga patsientidele.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Ka k\u00f5rvaltoimeid on v\u00e4hem ja patsientide elukvaliteet parem<\/h3>\n\n\n\n<p>Uuringus osales 512 patsienti USA v\u00e4hikeskustes: 384 osalejat raviti T-DM1-ga ja 128 said ravi keemiaravi ja trastuzumabiga. Uurijad leidsid, et viis aastat p\u00e4rast ravi ei olnud 97% T-DM1 saanud patsientidest v\u00e4hi kordumise tunnuseid. Kliiniliselt oluliste toksilisuse esinemissagedus oli T-DM1 ning keemiaravi ja trastuzumabi r\u00fchmas sarnane. Tulemused n\u00e4itavad aga paremat elukvaliteeti T-DM1-ga, mis oli seotud v\u00e4hema neuropaatia, v\u00e4iksema juuste v\u00e4ljalangemise ja parema t\u00f6\u00f6viljakusega.<\/p>\n\n\n\n<p>&#8220;ATEMPT uuring on meile \u00f5petanud, et 1. staadiumi HER2-positiivse v\u00e4higa patsientidel on \u00fcheaastane T-DM1 p\u00e4rast operatsiooni saavutatud silmapaistvaid pikaajalisi tulemusi, muutes selle valitud patsientide jaoks m\u00f5istlikuks raviviisiks,&#8221; \u00fctleb vanemautor Sara Tolaney, Dana-Farberi v\u00e4hiinstituudi rinnaonkoloogia osakonna juhataja.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"683\" height=\"1024\" src=\"https:\/\/terviseleht.eu\/wp-content\/uploads\/2024\/06\/pexels-marcelodias-2010877-683x1024.jpg\" alt=\"\" class=\"wp-image-641\" srcset=\"https:\/\/terviseleht.eu\/wp-content\/uploads\/2024\/06\/pexels-marcelodias-2010877-683x1024.jpg 683w, https:\/\/terviseleht.eu\/wp-content\/uploads\/2024\/06\/pexels-marcelodias-2010877-200x300.jpg 200w, https:\/\/terviseleht.eu\/wp-content\/uploads\/2024\/06\/pexels-marcelodias-2010877-768x1152.jpg 768w, https:\/\/terviseleht.eu\/wp-content\/uploads\/2024\/06\/pexels-marcelodias-2010877-1024x1536.jpg 1024w, https:\/\/terviseleht.eu\/wp-content\/uploads\/2024\/06\/pexels-marcelodias-2010877.jpg 1280w\" sizes=\"(max-width: 683px) 100vw, 683px\" \/><\/figure>\n\n\n\n<p>Photo by Marcelo Dias. <\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"679\" height=\"679\" src=\"https:\/\/terviseleht.eu\/wp-content\/uploads\/2024\/07\/71pzg7zGvL._AC_SX679_.jpg\" alt=\"\" class=\"wp-image-728\" srcset=\"https:\/\/terviseleht.eu\/wp-content\/uploads\/2024\/07\/71pzg7zGvL._AC_SX679_.jpg 679w, https:\/\/terviseleht.eu\/wp-content\/uploads\/2024\/07\/71pzg7zGvL._AC_SX679_-300x300.jpg 300w, https:\/\/terviseleht.eu\/wp-content\/uploads\/2024\/07\/71pzg7zGvL._AC_SX679_-150x150.jpg 150w\" sizes=\"(max-width: 679px) 100vw, 679px\" \/><\/figure>\n\n\n\n<p><a href=\"https:\/\/amzn.to\/3zRELee\" target=\"_blank\" rel=\"noopener nofollow sponsored\" title=\"\">Need treeninguvahendid pakuvad mitmek\u00fclgset lahendust erinevate lihasr\u00fchmade, sealhulgas jalgade, tuhara ja puusade treenimiseks, etsaavutada kehakuju, mida soovite. Pahkluu mansetid on varustatud rihmadega, mida saab h\u00f5lpsasti reguleerida. See tagab turvalisuse ja mugavuse treeningute ajal, v\u00f5imaldades teil keskenduda oma harjutustele, muretsemata, et rihmad maha libisevad.<\/a>\u00a0(Amazon)<\/p>\n\n\n\n<p>Loe ka <a href=\"https:\/\/terviseleht.eu\/?p=560\" title=\"\">Odav arginiin v\u00f5ib t\u00f5hustada v\u00e4hi kiiritusravi<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dana-Farberi v\u00e4hiinstituudi teadlaste juhitud meeskond leidis, et aasta kestnud ravi antikehast ja keemiaravist valmistatud ravimiga on osutunud v\u00e4ga t\u00f5husaks 1. staadiumi HER2-positiivse rinnav\u00e4hi kordumise \u00e4rahoidmisel. Kliinilises uuringus osales 512 varases&hellip; <\/p>\n","protected":false},"author":2,"featured_media":643,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[9,7],"tags":[789,247,652,791,785,793,788,790,21,792,787,625,784,660,786,243],"class_list":["post-640","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ennetus","category-ravi-ja-ravimid","tag-antikeha","tag-cancer","tag-eesti-vahiliit","tag-elulemus","tag-her2-2","tag-juuste-valjalangemine","tag-keemiaravi","tag-metastaasid","tag-naised","tag-neuropaatia","tag-oncology","tag-operatsioon","tag-rinnad","tag-rinnavahk","tag-staadium","tag-vahk"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/terviseleht.eu\/index.php?rest_route=\/wp\/v2\/posts\/640"}],"collection":[{"href":"https:\/\/terviseleht.eu\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/terviseleht.eu\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/terviseleht.eu\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/terviseleht.eu\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=640"}],"version-history":[{"count":5,"href":"https:\/\/terviseleht.eu\/index.php?rest_route=\/wp\/v2\/posts\/640\/revisions"}],"predecessor-version":[{"id":781,"href":"https:\/\/terviseleht.eu\/index.php?rest_route=\/wp\/v2\/posts\/640\/revisions\/781"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/terviseleht.eu\/index.php?rest_route=\/wp\/v2\/media\/643"}],"wp:attachment":[{"href":"https:\/\/terviseleht.eu\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=640"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/terviseleht.eu\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=640"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/terviseleht.eu\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=640"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}